Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Saad Usmani, MD, University of North Carolina School of Medicine, Chapel Hill, NC, discusses the successes of the COMy meeting. Since the last virtual meeting in May, there has been new data to highlight and discuss. This interview took place during the Controversies in Multiple Myeloma (COMy) 2020 Virtual World Congress.
Disclosures
Saad Z. Usmani reports consulting for Abbvie, Amgen, BMS, Celgene, GSK, Janssen, Merck, Takeda, Sanofi and SkylineDx; speaker’s fees for Amgen, Celgene, Janssen, Sanofi and Takeda; and research funding from Amgen, Array Biopharma, BMS, Celgene, GSK, Janssen, Merck, Pharmacyclics, Sanofi, Seattle Genetics, SkylineDX, Takeda.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.